Understand the ingredient you are evaluating.
Discuss constituent form, content specifications, analytical methods, quality documentation and sample conditions. Confirm that the information matches the version to be supplied.
Discuss ZeaSight™A research-led startfor your nutrition concept.
Connect microbial research and ingredient information with the development needs of your nutraceutical brand.

ZeaSight™ is Visgeneer’s branded microbial-source free-form zeaxanthin ingredient, based on Olleya marilimosa research and fermentation technology. This page offers nutraceutical brands a starting point for ingredient assessment and development discussions.
Supply specifications, available documentation and target-market suitability are confirmed for each project.
Zeaxanthin and lutein are distinct carotenoids found in the macula and discussed in visual-nutrition research. Brand development also needs a clear understanding of source, form, content and formulation conditions.
Explore the research context of Olleya marilimosa and fermentation.
Review constituent form, content, analytical methods and batch specifications as the basis for assessment.
Bring your target market, intended format and labelling needs into the discussion to plan relevant documentation and validation.
Define the intended audience and market, then identify the technical information and formulation assessment needed.
Discuss constituent form, content specifications, analytical methods, quality documentation and sample conditions. Confirm that the information matches the version to be supplied.
Discuss ZeaSight™Explore combinations with ingredients such as lutein, then assess dispersion, processing conditions, stability and packaging for the intended product format.
Discuss ZeaSight™Identify ingredient-use, labelling and claim requirements for the destination country or region. Market-entry conditions depend on the applicable review of the ingredient and product.
Discuss ZeaSight™Vigenent’s 2016 microbial zeaxanthin publication includes in-vitro antioxidant and cell-based experiments. General zeaxanthin literature, studies of specific formulas and ZeaSight™ finished-product evidence should be considered separately. AREDS2 findings are not presented here as clinical validation of ZeaSight™.
Ken-Shwo Dai · 2016 · DOI 10.2174/1874464809666161006165239No. ZeaSight™ focuses on zeaxanthin, while lutein is a different carotenoid. Their roles, proportions and inclusion levels should be evaluated for the specific product and available evidence.
ZeaSight™ focuses on zeaxanthin and nutraceutical partnerships. Ollantein® is a fermented ingredient brand presented here for skincare formulation applications. Composition, specifications and applicable evidence should be assessed separately.
Send an ingredient inquiry with your company, target market, intended format and development stage. The team will confirm available specifications, analytical data, sample conditions and supply arrangements.
Public microbial zeaxanthin research and patent records provide a starting point. In-vitro and cell-based studies offer research direction; human efficacy and finished-product claims require corresponding product evidence.
Conditions for ingredient use and claims vary by market, source, specification and product format. Provide the intended sales region so the relevant documentation and conditions can be assessed.
Share your target market, intended format and development stage to start a focused ingredient discussion.